Evidence map›Paper›PMID 32715374›Full record

ArticleCell and tissue research2020

Transplantation of R-GSIK scaffold with mesenchymal stem cells improves neuroinflammation in a traumatic brain injury model.

Sajad Sahab Negah, Mohammad Moein Shirzad, Ghazale Biglari, Farzin Naseri, Hassan Hosseini Ravandi, Ali Hassani Dooghabadi, Ali Gorji

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cell and tissue research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sajad Sahab NegahNeuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Moein ShirzadStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Ghazale BiglariStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Farzin NaseriStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Hassan Hosseini RavandiShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.
Ali Hassani DooghabadiStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Ali GorjiNeuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. gorjial@uni-muenster.de.ORCID http://orcid.org/0000-0002-4557-3270
Mashhad University of Medical Sciences · IRKhatam University · IR

Funding

Iran National Science Foundation Neuroscience ChairMashhad University of Medical Sciences Student Grant
6 · The paper itself

Abstract

Neural tissue engineering has been introduced as a novel therapeutic strategy for traumatic brain injury (TBI). Transplantation of mesenchymal stem cells (MSCs) has been demonstrated to improve functional outcome of brain injury, and RADA4GGSIKVAV (R-GSIK), a self-assembling nano-peptide scaffold, has been suggested to promote the behavior of stem cells. This study was designed to determine the ability of the R-GSIK scaffold in supporting the effects of MSCs on motor function activity and inflammatory responses in an experimental TBI model. A significant recovery of motor function was observed in rats that received MSCs+R-GSIK compared with the control groups. Further analysis showed a reduction in the number of reactive astrocytes and microglial cells in the MSCs and MSCs+R-GSIK groups compared with the control groups. Furthermore, western blot analysis indicated a significant reduction in pro-inflammatory cytokines, such as TLR4, TNF, and IL6, in the MSCs and MSCs+R-GSIK groups compared with the TBI, vehicle, and R-GSIK groups. Overall, this study strengthens the idea that the co-transplantation of MSCs with R-GSIK can increase functional outcomes by preparing a beneficial environment. This improvement may be explained by the immunomodulatory effects of MSCs and the self-assembling nano-scaffold peptide.

Indexed as

AnimalsBrain Injuries, TraumaticCell DifferentiationDisease Models, AnimalMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationPeptidesRatsRats, WistarTissue ScaffoldsPeptidesHead injuryNano-scaffoldNeuroinflammationStem cells

Identifiers

PMID32715374
PMCPMC7683465
OpenAlexW3045350517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.